The Lupus Foundation of America (LFA) is excited to share that enrollment for the MiSLE (Mesenchymal Stromal Cells in ...

The Lupus Research Alliance (LRA) is proud to announce the recipients of this year’s Lupus Innovation Award (LIA), addressing many critical themes in lupus research including novel therapeutic ...

Health experts have warned that many Nigerians who are diagnosed and treated for malaria or typhoid more than 10 times in a ...

The FDA bestows a Regenerative Medicine Advanced Therapy tag on FATE's pipeline candidate, FT819, for treating moderate-to-severe systemic lupus erythematosus.

The trial will assess the therapy’s pharmacokinetics, pharmacodynamics and safety, as well as its impact on disease activity.

Assistant Professor Andrew Monteith's lab in the Department of Microbiology is documenting how key immune cells detect infection and how that fails to happen in people with lupus. Research ...

From agonising misdiagnoses and delayed treatments to the devastating emotional and financial burden, Idowu Abdullahi writes ...

Dr. Kean has engineered Tregs with CARs that recognize OX40L, a molecule on the surface of immune cells in people with active lupus. She will now test these “OX40L-CAR-Tregs" in human cells and ...

Boehringer Ingelheim has joined the surge of companies entering the B-cell depletion space. But while its peers have largely ...

"Equally exciting is the discovery that this lupus antibody delivers genes to cells without needing any help from a virus, meaning it could be used to transform gene therapy strategies." ...

Researchers who discovered a mechanism that prevents B cells from attacking the body’s own tissues in autoimmune diseases win ...